Key Documents

View All Documentation

SML2260

Taspoglutide trifluoroacetate salt

Name: Taspoglutide trifluoroacetate salt
Brand: SIGMA

≥95% (HPLC), GLP-1 receptor agonist, lyophilized powder

Synonym(s):

8-(2-Methylalanine)-35-(2-methylalanine)-36-L-argininamide-7-36-glucagon-like peptide I (human) trifluoroacetate salt, BIM 51077 trifluoroacetate salt, R1583 trifluoroacetate salt, RO 5073031 trifluoroacetate salt, [Aib8,35]hGLP-1(7-36)NH2; H-His-2-methyl-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-2-methyl-Ala-Arg-CONH2 trifluoroacetate salt

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₅₂H₂₃₂N₄₀O₄₅ · xC₂HF₃O₂

CAS Number:

275371-94-3

Molecular Weight:

3339.71 (free base basis)

UNSPSC Code:

51111800

NACRES:

NA.77

Assay:

≥95% (HPLC)

Form:

lyophilized powder

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Product Name

Taspoglutide trifluoroacetate salt, ≥95% (HPLC)

assay

≥95% (HPLC)

form

lyophilized powder

color

white to beige

shipped in

wet ice

storage temp.

−20°C

Related Categories

Bioactive Small Molecules

Biochem/physiol Actions

Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist. Taspoglutide improves glucose tolerance, postprandial glucose, body weight, glycaemic control and insulin sensitivity in the Zucker diabetic fatty rat.

long-acting glucagon-like peptide 1 (GLP-1) receptor agonist

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Taspoglutide, a novel human once-weekly analogue of glucagon-like peptide-1, improves glucose homeostasis and body weight in the Zucker diabetic fatty rat.

E Sebokova et al.

Diabetes, obesity & metabolism, 12(8), 674-682 (2010-07-02)

Glucagon-like peptide-1 (GLP-1) receptor agonists are a novel class of pharmacotherapy for type 2 diabetes. We investigated the effects of a novel, long-acting human GLP-1 analogue, taspoglutide, in the Zucker diabetic fatty (ZDF) rat, an animal model of type 2

Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.

K Pabreja et al.

British journal of pharmacology, 171(5), 1114-1128 (2013-07-31)

The incidence of type 2 diabetes in developed countries is increasing yearly with a significant negative impact on patient quality of life and an enormous burden on the healthcare system. Current biguanide and thiazolidinedione treatments for type 2 diabetes have

Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.

S R K Seshasai et al.

Diabetes, obesity & metabolism, 17(5), 505-510 (2015-02-07)

To study the short-term cardiovascular effects of the once-weekly glucagon-like peptide-1 receptor agonist taspoglutide. We conducted a meta-analysis of individual-participant data from nine randomized controlled trials in the T-Emerge programme, which assessed the efficacy and safety of taspoglutide in type

Global Trade Item Number

SKU	GTIN
SML2260-25MG	04061835496532
SML2260-5MG	04061835496549

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service